Opus Genetics has completed a Type B Regenerative Medicine Advanced Therapy (RMAT) meeting with the US Food and Drug ...

Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.24 per share. This compares to earnings of $0.31 per share a ...

Large-scale analyses connect genetic risk factors in lupus with ACR-82 clinical manifestations, suggesting genetic risk ...

Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.44 per share a year ago. These ...

HLA class I alleles, one known and one newly identified, are linked to allopurinol-induced severe cutaneous adverse reactions ...

Dr. McGuire received her B.A. from the University of Pennsylvania, summa cum laude, her J.D. from the University of Houston ...

Q2 2026 Earnings Call November 5, 2025 8:00 AM ESTCompany ParticipantsSimona King - Chief Financial OfficerMiguel Martin - ...

The prize, honoring “the most outstanding plant scientists working on both genetics and genomics in the present era,” is named after McClintock, a plant biologist whose work in maize genetics earned ...

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and ...

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...

We are entering the third decade of the 21st century, witnessing extraordinary breakthroughs across various scientific domains, notably in the dynamic ...

FRIDAY, Oct. 31, 2025 (HealthDay News) — Millions of Americans carry hidden genetic mutations that increase their risk of ...